Bioventus Inc.
BVS
$8.97
-$0.18-1.97%
NASDAQ
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 367.67% | -57.70% | 382.86% | -579.64% | 92.49% |
| Total Depreciation and Amortization | -222.93% | -5.36% | 1.55% | 165.87% | -246.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 463.27% | -18.31% | 125.32% | -92.29% | 834.88% |
| Change in Net Operating Assets | -41.87% | 2,138.36% | 101.53% | -1,380.12% | -360.26% |
| Cash from Operations | 26.15% | 16.04% | 234.18% | -200.05% | 87.30% |
| Capital Expenditure | -22.62% | 30.75% | 17.31% | -43.90% | -796.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 100.00% | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22.62% | 65.45% | -65.74% | -103.43% | 37,762.50% |
| Total Debt Issued | -100.00% | -- | -100.00% | -- | -- |
| Total Debt Repaid | -87.88% | -206.04% | 0.00% | 89.64% | -- |
| Issuance of Common Stock | 432.29% | -92.71% | 778.00% | -86.40% | 99.46% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.69% | -507.19% | -19.31% | -313.73% | 2,354.45% |
| Cash from Financing | -42.40% | -36.24% | -1,648.36% | 102.21% | -11,938.40% |
| Foreign Exchange rate Adjustments | 133.76% | -295.05% | -53.02% | 120.84% | -542.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.95% | -8.45% | 153.82% | -1,158.71% | -113.47% |